#USA #Chicago #Aon #Cancer Care #Thyme Care

Introduction

Thyme Care, in collaboration with the American Oncology Network (AON), has made significant strides in the field of value-based cancer care. Their partnership aims to revolutionize how cancer care is measured and delivered, providing enhanced outcomes and patient experiences. During the American Society of Clinical Oncology (ASCO) Quality Symposium 2025 held in Chicago on October 10-11, the two organizations presented nine research abstracts that profoundly demonstrate their combined expertise and innovative approaches.

The Research Presentations

The accepted research abstracts at ASCO Quality 2025 represent the culmination of work that underscores the importance of patient-centered care in oncology. By leveraging AON’s vast network of clinical insights and Thyme Care’s advanced technology and analytics framework, these studies reveal actionable findings that could influence policy and practical care strategies in the oncology field.

1. Informing Policy Design in the Enhancing Oncology Model - This research explores how the Enhancing Oncology Model (EOM) can be refined for better policy outcomes. It discusses crucial insights about health equity and the operational complexities within existing models. Five abstracts were presented that outline data-driven recommendations for overcoming common challenges in cancer care implementation.

2. Clinical Adjusters in the EOM - The study highlights how traditional cost groups can be misaligned with current treatment paradigms, particularly in breast cancer scenarios. By advocating for dynamic adjustments based on evolving drug costs and treatment patterns, it seeks to enhance accuracy.

3. Minimum Episode Volume Impact - It sheds light on the financial sustainability of oncology practices by advocating for clear communication about risk pooling and the necessity of minimum episode requirements.

4. Improving Patient Experience Through Smarter Care Delivery - This research aimed to reduce the treatment burden on patients, particularly those approaching the end of life. One key finding demonstrates that altering drug dosing regimens can significantly decrease the clinic visit frequency, thereby alleviating a formidable part of the treatment burden associated with cancer care.

5. Driving Policy Change for More Equitable Care - Both organizations noted that current care models may unintentionally disadvantage practices working with vulnerable populations. Their findings identified specific gaps within methodologies that could undermine these models' efficacy, providing recommendations to foster equity.

Real-World Application and Insights

Each of these studies emerged from a rich dataset compiled through AON's extensive clinical network, encompassing thousands of episodes from diverse oncology practices across multiple states. By analyzing these episodes, the organizations were able to glean insights that can directly inform clinical practices and health policies.

Dr. Bobby Green, co-founder and Chief Medical Officer at Thyme Care, remarked, "This collaborative research affirms the transformative power of integrating clinical care with data science. The profound acceptance of our abstracts by the ASCO Quality committee illustrates the significance of our shared mission to prioritize patient care outcomes."

Building a Foundation for Future Cancer Care

AON and Thyme Care's ongoing collaboration signifies more than just a partnership; it embodies a shared vision for reesteeming cancer care. By utilizing advanced analytics and real-time patient tracking, they aspire to move beyond traditional care concepts towards an integrated model that aligns operational effectiveness with patient-centric strategies.

This initiative is critical as it paves the way for value-based care models that focus not only on the cost of treatment but also on the quality of life for patients. Through their innovative approaches, they are creating a roadmap for future improvements in cancer care that prioritizes compassion, efficiency, and equity. As the oncology landscape continues to evolve, efforts from leaders like Thyme Care and AON are essential in ensuring that care remains accessible and effective for all cancer patients.

Conclusion

In conclusion, the research presented at ASCO Quality 2025 by Thyme Care and AON represents a significant leap toward improving value-based oncology practices. As they continue to refine their collaborative processes and extend their impact, the future of cancer care may become more compassionate, equitable, and patient-centered. As more advanced analytics become available, the oncology community will likely witness transformative changes in how care is delivered and measured.